HLA-DRB1*1501 Genotyping Multiple Sclerosis Test sale cost 1050 AED
TBG Thyroxine Binding Globulin Test sale cost 1280 AED TBG Thyroxine Binding Globulin Test Cost 1,430 د.إ Original price was: 1,430 د.إ.1,280 د.إCurrent price is: 1,280 د.إ.
SMALL BIOPSY BOTTLE NO 10 Test sale cost 1050 AED SMALL BIOPSY BOTTLE NO 10 Test Cost 1,400 د.إ Original price was: 1,400 د.إ.1,050 د.إCurrent price is: 1,050 د.إ.
Sale!

HLA-DRB1*1501 Genotyping Multiple Sclerosis Test Cost

Original price was: 1,400 د.إ.Current price is: 1,050 د.إ.

-25%

The HLA-DRB1*1501 Genotyping Multiple Sclerosis Test is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at identifying the presence of the HLA-DRB1*1501 allele, which has been strongly associated with an increased risk of developing Multiple Sclerosis (MS). Multiple Sclerosis is a chronic autoimmune disease that affects the central nervous system, leading to a wide range of symptoms that can impact an individual’s daily life. The presence of the HLA-DRB1*1501 allele does not confirm that a person will develop MS, but it can significantly contribute to understanding an individual’s risk profile.

The test involves a simple blood draw or cheek swab, after which the sample is analyzed in the laboratory to detect the specific genetic marker. It is particularly useful for individuals with a family history of MS or those who have early symptoms of the disease, as it can provide valuable information for risk assessment and management strategies.

At DNA Labs UAE, the cost of the HLA-DRB1*1501 Genotyping Multiple Sclerosis Test is set at 1050 AED. The test is conducted under stringent quality control measures, ensuring accurate and reliable results. Individuals who undergo this test can expect to receive their results along with comprehensive guidance from healthcare professionals on the implications of the findings and potential next steps in managing their health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HLA-DRB1*1501 Genotyping Multiple Sclerosis Test

Cost: AED 1050.0

Symptoms, Diagnosis, and Test Details

The HLA-DRB1*1501 Genotyping Multiple Sclerosis Test is a genetic test offered by DNA Labs UAE. This test helps determine the presence of the HLA-DRB1*1501 allele in an individual’s DNA. This allele has been found to be associated with an increased risk of developing multiple sclerosis (MS), a chronic autoimmune disease affecting the central nervous system.

Multiple sclerosis is believed to be caused by a combination of genetic and environmental factors. The HLA-DRB1*1501 allele is considered one of the most significant genetic risk factors for MS. Individuals who carry this allele have a higher susceptibility to developing the disease compared to those who do not.

The HLA-DRB1*1501 genotyping test is typically performed using a blood or saliva sample. The DNA is extracted from the sample, and specific genetic markers associated with the HLA-DRB1*1501 allele are analyzed. The presence or absence of these markers determines whether an individual carries the allele.

It is important to note that not all individuals with the HLA-DRB1*1501 allele will develop MS, and not all individuals with MS carry this allele. Therefore, this test is not a definitive diagnostic tool for MS but rather a tool to assess an individual’s genetic susceptibility to the disease.

Pre-Test Information and Test Process

HLA-DRB1*1501 Genotyping (Multiple Sclerosis) can be done with a doctor’s prescription. However, the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

The test requires a 2ml EDTA Vacutainer blood sample in good condition. The cost of the test is AED 1050.0, and the report will be delivered within 10 days. The method used for this test is Sanger Sequencing, a reliable technique for analyzing genetic sequences.

The HLA-DRB1*1501 Genotyping Multiple Sclerosis Test falls under the genetics department and is typically recommended by gynecologists.

Implications and Benefits

The results of HLA-DRB1*1501 genotyping can help assess the risk of developing multiple sclerosis. However, it is important to consult with a healthcare professional or genetic counselor to understand the implications of the results and how they may impact an individual’s risk for developing MS.

It is also crucial to note that the information obtained from this test should be used in combination with other clinical and laboratory findings to aid in the diagnosis and management of MS. Additionally, it can be used to identify individuals who may benefit from early intervention or specific treatment options.

To get a better understanding of the HLA-DRB1*1501 genotyping results and their implications, it is recommended to consult with a healthcare professional or genetic counselor.

Test Name HLA-DRB1*1501 Genotyping Multiple Sclerosis Test
Components EDTA Vacutainer (2ml)
Price 1050.0 AED
Sample Condition Peripheral blood
Report Delivery 10 days
Method Sanger Sequencing
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information HLA-DRB1*1501 Genotyping (Multiple Sclerosis) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

HLA-DRB1*1501 genotyping is a genetic test used to determine the presence of the HLA-DRB1*1501 allele in an individual’s DNA. This allele has been found to be associated with an increased risk of developing multiple sclerosis (MS), a chronic autoimmune disease that affects the central nervous system.

Multiple sclerosis is believed to be caused by a combination of genetic and environmental factors. The HLA-DRB1*1501 allele is one of the most significant genetic risk factors for MS. Individuals who carry this allele have an increased susceptibility to developing the disease compared to those who do not.

HLA-DRB1*1501 genotyping is typically performed using a blood or saliva sample. The DNA is extracted from the sample and specific genetic markers associated with the HLA-DRB1*1501 allele are analyzed. The presence or absence of these markers determines whether an individual carries the allele.

The results of HLA-DRB1*1501 genotyping can help in assessing the risk of developing MS. However, it is important to note that not all individuals with the HLA-DRB1*1501 allele will develop MS, and not all individuals with MS carry this allele. Therefore, this test is not a definitive diagnostic tool for MS, but rather a tool to assess an individual’s genetic susceptibility to the disease.

The information obtained from HLA-DRB1*1501 genotyping can be used in combination with other clinical and laboratory findings to aid in the diagnosis and management of MS. It can also be used to identify individuals who may benefit from early intervention or specific treatment options.

It is important to consult with a healthcare professional or genetic counselor to understand the implications of HLA-DRB1*1501 genotyping results and how they may impact an individual’s risk for developing MS.

SKU: TEST-5554